Aclaris Therapeutics: HC Wainwright Raises Buy Rating to $16.

Thursday, Mar 19, 2026 8:17 am ET1min read
ACRS--

Aclaris Therapeutics: HC Wainwright Raises Buy Rating to $16.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet